Format

Send to

Choose Destination
JAMA Oncol. 2016 Feb;2(2):165-6. doi: 10.1001/jamaoncol.2015.5359.

Application of Medicare's New Technology Add-on Payment Program for Blinatumomab.

Author information

1
Robert Wood Johnson Foundation Clinical Scholars Program, Yale University School of Medicine, New Haven, Connecticut2Department of Internal Medicine, Connecticut Veterans Affairs Health System, West Haven, Connecticut.
2
Division of Hematology-Oncology, Knight Cancer Institute, Department of Public Health and Preventive Medicine, Oregon Health and Sciences University, Portland.
PMID:
26720844
DOI:
10.1001/jamaoncol.2015.5359
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center